180 related articles for article (PubMed ID: 9737934)
41. Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.
Ma X; Iyer SR; Ma X; Reginauld SH; Chen Y; Pan S; Zheng Y; Moroni DG; Yu Y; Zhang L; Cannone V; Chen HH; Ferrario CM; Sangaralingham SJ; Burnett JC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239899
[TBL] [Abstract][Full Text] [Related]
42. Peroxynitrite inhibits the expression of G(i)alpha protein and adenylyl cyclase signaling in vascular smooth muscle cells.
Bassil M; Li Y; Anand-Srivastava MB
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H775-84. PubMed ID: 18055527
[TBL] [Abstract][Full Text] [Related]
43. Differential regulation of G-protein expression by vasoactive peptides.
Anand-Srivastava MB; Palaparti A; Pion J
Mol Cell Biochem; 1997 Nov; 176(1-2):21-7. PubMed ID: 9406140
[TBL] [Abstract][Full Text] [Related]
44. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor.
Murthy KS; Teng BQ; Zhou H; Jin JG; Grider JR; Makhlouf GM
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G974-80. PubMed ID: 10859228
[TBL] [Abstract][Full Text] [Related]
45. Atrial natriuretic peptide-C receptor and membrane signalling in hypertension.
Anand-Srivastava MB
J Hypertens; 1997 Aug; 15(8):815-26. PubMed ID: 9280203
[TBL] [Abstract][Full Text] [Related]
46. Role of PKCα-p38 MAPK-Giα axis in peroxynitrite-mediated inhibition of β-adrenergic response in pulmonary artery smooth muscle cells.
Chakraborti S; Roy S; Chowdhury A; Mandal A; Chakraborti T
Cell Signal; 2013 Feb; 25(2):512-26. PubMed ID: 23159577
[TBL] [Abstract][Full Text] [Related]
47. Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells.
Sharma GD; Nguyen HT; Antonov AS; Gerrity RG; von Geldern T; Pandey KN
Mol Cell Biochem; 2002 Apr; 233(1-2):165-73. PubMed ID: 12083372
[TBL] [Abstract][Full Text] [Related]
48. Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2.
Frank GD; Saito S; Motley ED; Sasaki T; Ohba M; Kuroki T; Inagami T; Eguchi S
Mol Endocrinol; 2002 Feb; 16(2):367-77. PubMed ID: 11818507
[TBL] [Abstract][Full Text] [Related]
49. Studies on the mechanism of the novel stimulatory effect of angiotensin-II on adenylate cyclase in rat fetal skin fibroblasts.
Johnson MC; Aguilera G
Endocrinology; 1992 Nov; 131(5):2404-12. PubMed ID: 1330500
[TBL] [Abstract][Full Text] [Related]
50. Protein kinase C modulates natriuretic peptide receptors in astroglial cultures from rat brain.
Paulding WR; Sumners C
Am J Physiol; 1996 Mar; 270(3 Pt 1):C740-7. PubMed ID: 8638652
[TBL] [Abstract][Full Text] [Related]
51. Streptozotocin-induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle.
Hashim S; Liu YY; Wang R; Anand-Srivastava MB
Mol Cell Biochem; 2002 Nov; 240(1-2):57-65. PubMed ID: 12487372
[TBL] [Abstract][Full Text] [Related]
52. Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways.
Hashim S; Li Y; Anand-Srivastava MB
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H3144-53. PubMed ID: 16920814
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.
Leite-Moreira AF; Castro-Chaves P; Pimentel-Nunes P; Lima-Carneiro A; Guerra MS; Soares JB; Ferreira-Martins J
Br J Pharmacol; 2006 Mar; 147(6):690-7. PubMed ID: 16415904
[TBL] [Abstract][Full Text] [Related]
54. Role of oxidative stress in high glucose-induced decreased expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells.
Li Y; Descorbeth M; Anand-Srivastava MB
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2845-54. PubMed ID: 18441196
[TBL] [Abstract][Full Text] [Related]
55. Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle.
Yasunari K; Kohno M; Murakawa K; Yokokawa K; Horio T; Takeda T
Hypertension; 1992 Apr; 19(4):314-9. PubMed ID: 1348239
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase.
Marcil J; de Champlain J; Anand-Srivastava MB
Cardiovasc Res; 1998 Aug; 39(2):492-505. PubMed ID: 9798534
[TBL] [Abstract][Full Text] [Related]
57. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh H; Pratt RE; Dzau VJ
J Clin Invest; 1990 Nov; 86(5):1690-7. PubMed ID: 2173726
[TBL] [Abstract][Full Text] [Related]
58. Cytoplasmic domain of natriuretic peptide receptor C constitutes Gi activator sequences that inhibit adenylyl cyclase activity.
Pagano M; Anand-Srivastava MB
J Biol Chem; 2001 Jun; 276(25):22064-70. PubMed ID: 11303026
[TBL] [Abstract][Full Text] [Related]
59. Losartan-induced attenuation of blood pressure in L-NAME hypertensive rats is associated with reversal of the enhanced expression of Gi alpha proteins.
Hashim S; Anand-Srivastava MB
J Hypertens; 2004 Jan; 22(1):181-90. PubMed ID: 15106810
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells.
Kawabe J; Ohsaki Y; Onodera S
Biochim Biophys Acta; 1992 Dec; 1175(1):81-7. PubMed ID: 1362357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
